THE METABOLISM OF CYCLOPHOSPHAMIDE. DOSE DEPENDENCY AND THE EFFECT OF LONG-TERM TREATMENT WITH CYCLOPHOSPHAMIDEMOURIDSEN HT; FABER O; SJOVSTED L et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 37; NO 2; PP. 665-670; BIBL. 21 REF.Article

THE BIOTRANSFORMATION OF CYCLOPHOSPHAMIDE IN MAN. ANALYSIS OF THE VARIATION IN NORMAL SUBJECTSMOURIDSEN HT; FABER O; SKOVSTED L et al.1974; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1974; VOL. 35; NO 2; PP. 98-106; BIBL. 1P.1/2Article

THE PHARMACOKINETICS OF CYCLOPHOSPHAMIDE IN MAN FOLLOWING TREATMENT WITH METHOTREXATE = PHARMACOCINETIQUE DU CYCLOPHOSPHAMIDE CHEZ L'HOMME APRES TRAITEMENT PAR LE METHOTREXATEMOURIDSEN HT; JACOBSEN E; FABER O et al.1976; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1976; VOL. 38; NO 5; PP. 508-512; BIBL. 7 REF.Article

THERAPEUTIC EFFECT OF TOLBUTAMIDE IN NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). RELATION TO BETA-CELL FUNCTIONDAMSGAARD EM; FABER O; FROLAND A et al.1982; ACTA ENDOCRINOL. (KBH.); ISSN 0001-5598; DNK; DA. 1982; VOL. 100; NO 3; PP. 416-420; BIBL. 22 REF.Article

C-PEPTIDE AND INSULIN DURING BLOCKADE OF THE HYPER-GLYCAEMIC REPONSE TO SURGERY BY EPIDURAL ANALGESIA.BRANDT MR; KEHLET H; FABER O et al.1977; CLIN. ENDOCRINOL.; G.B.; DA. 1977; VOL. 6; NO 2; PP. 167-170; BIBL. 13 REF.Article

Renovation : a thoughtful and multi-disciplinary approachSINGH, J; FABER, O.Construction repair (1992). 1996, Vol 10, Num 3, pp 40-42, issn 0967-0726Article

Intramolekulare Aromatenalkylierungen. XXXI: Synthese und Cyclisierung von 1,4-Dimethyl-3-phenethyl-1,2,3,6-tetrahydropyridin = Intramolecular alkylation of aromatic compounds. XXXI: Synthesis and cyclisation of 1,4-dimethyl-3-phenyl-ethyl-1,2,3,6-tetrahydropyridineREIMANN, E; FABER, O.Archiv der Pharmazie (Weinheim). 1994, Vol 327, Num 2, pp 125-128, issn 0365-6233Article

HYPOMAGNESEMIA, A RISK FACTOR IN DIABETIC RETINOPATHYMCNAIR P; CHRISTIANSEN C; MADSBAD S et al.1978; DIABETES; USA; DA. 1978; VOL. 27; NO 11; PP. 1075-1077; BIBL. 15 REF.Article

Splanchnic extraction of 3,3'-diiodothyronine and 3',5'-diiodothyronine in hyperthyroidismFABER, J; FABER, O; WENNLUND, A et al.The Journal of clinical endocrinology and metabolism. 1984, Vol 59, Num 1, pp 147-150, issn 0021-972XArticle

Lack of influence of residual β-cell function on the glucagon and pancreatic polypeptide secretion in type I (insulin-dependent) diabetic patientsTRONIER, B; MADSBAD, S; KRARUP, T et al.Diabète et métabolisme (Paris). 1987, Vol 13, Num 2, pp 141-143, issn 0338-1684Article

Renal threshold for glucose in non-insulin-dependent diabetic patientsRUHNAU, B; FABER, O. K; BORCH-JOHNSEN, K et al.Diabetes research and clinical practice. 1997, Vol 36, Num 1, pp 27-33, issn 0168-8227Article

Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetesGJESSING, H. J; MATZEN, L. E; FABER, O. K et al.Diabetologia (Berlin). 1989, Vol 32, Num 5, pp 305-311, issn 0012-186X, 7 p.Article

Glucose tolerance and B cell function in chronic alcoholism: its relation to hepatic histology and exocrine pancreatic functionANDERSEN, B. N; HAGEN, C; FABER, O. K et al.Metabolism, clinical and experimental. 1983, Vol 32, Num 11, pp 1029-1032, issn 0026-0495Article

Insulin action and insulin secretion in identical twins with MODY: evidence for defects in both insulin action and secretionBECK-NIELSEN, H; NIELSEN, O. H; PEDERSEN, O et al.Diabetes (New York, NY). 1988, Vol 37, Num 6, pp 730-735, issn 0012-1797Article

Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitusKRARUP, T; MADSBAD, S; REGEUR, L et al.Acta endocrinologica (Oslo). 1984, Vol 105, Num 2, pp 221-225, issn 0001-5598Article

Metabolic effect of islet B-cell function in insulin-treated diabetesGJESSING, H. J; MATZEN, L. E; IVERSEN, S et al.Scandinavian journal of clinical & laboratory investigation. 1989, Vol 49, Num 4, pp 337-343, issn 0036-5513, 7 p.Article

Insulin requirements in non-insulin-dependent diabetes mellitus: relation to simple tests of islet B-cell function and insulin sensitivityGJESSING, H. J; MATZEN, L. E; PEDERSEN, P. C et al.Diabetic medicine. 1988, Vol 5, Num 4, pp 328-332, issn 0742-3071Article

ELISA for human proinsulinHARTLING, S. G; DINESEN, B; KAPPELGARD, A.-M et al.Clinica chimica acta. 1986, Vol 156, Num 3, pp 289-297, issn 0009-8981Article

The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetesGJESSING, H. J; DAMSGAARD, E. M; MATZEN, L. E et al.Scandinavian journal of clinical & laboratory investigation. 1988, Vol 48, Num 8, pp 771-777, issn 0036-5513Article

The effect of insulin deprivation on fasting levels of 5000 Dalton gastric inhibitory polypeptide in type 1 (insulin dependent) diabeticsKRARUP, T; MADSBAD, S; REGEUR, L et al.Diabète et métabolisme (Paris). 1985, Vol 11, Num 6, pp 364-367, issn 0338-1684Article

Propriétés thermoélectriques et magnétiques des modifications α et β de (BEDT-TTF)₂I₃MERZHANOV, V. A; KOSTYUCHENKO, E. EH; FABER, O. E et al.ZETF. Pis′ma v redakciû. 1985, Vol 89, Num 1, pp 292-297, issn 0044-4510Article

Transmyocardial laser revascularisation in acutely ischaemic myocardium. Discussions. Author's replyMUELLER, X. M; TEVAEARAI, H. H; GENTON, C.-Y et al.European journal of cardio-thoracic surgery. 1998, Vol 13, Num 2, pp 170-175, issn 1010-7940Conference Paper